Peter S Knight - Net Worth and Insider Trading
Peter S Knight Net Worth
The estimated net worth of Peter S Knight is at least $28,958 dollars as of 2024-11-13. Peter S Knight is the Director of bioAffinity Technologies Inc and owns about 22,448 shares of bioAffinity Technologies Inc (BIAF) stock worth over $28,958. Details can be seen in Peter S Knight's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter S Knight has not made any transactions after 2022-08-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Peter S Knight
Peter S Knight Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter S Knight owns 2 companies in total, including CASI Pharmaceuticals Inc (CASI) , and bioAffinity Technologies Inc (BIAF) .
Click here to see the complete history of Peter S Knight’s form 4 insider trades.
Insider Ownership Summary of Peter S Knight
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CASI | CASI Pharmaceuticals Inc | 2003-10-21 | director |
| BIAF | bioAffinity Technologies Inc | 2022-08-31 | director |
Peter S Knight Latest Holdings Summary
Peter S Knight currently owns a total of 1 stock. Peter S Knight owns 22,448 shares of bioAffinity Technologies Inc (BIAF) as of August 31, 2022, with a value of $28,958.
Latest Holdings of Peter S Knight
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BIAF | bioAffinity Technologies Inc | 2022-08-31 | 22,448 | 1.29 | 28,958 |
Holding Weightings of Peter S Knight
Peter S Knight Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter S Knight has made a total of 1 transactions in bioAffinity Technologies Inc (BIAF) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in bioAffinity Technologies Inc is the acquisition of 8,163 shares on August 31, 2022, which cost Peter S Knight around $24,897.
Insider Trading History of Peter S Knight
- 1
Peter S Knight Trading Performance
Peter S Knight Ownership Network
Ownership Network List of Peter S Knight
Ownership Network Relation of Peter S Knight
Peter S Knight Owned Company Details
What does CASI Pharmaceuticals Inc do?
Who are the key executives at CASI Pharmaceuticals Inc?
Peter S Knight is the director of CASI Pharmaceuticals Inc. Other key executives at CASI Pharmaceuticals Inc include director & 10 percent owner & Chairman and CEO Wei-wu He , Chief Financial Officer Weihao Xu , and President Larry Zhang .
CASI Pharmaceuticals Inc (CASI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of CASI Pharmaceuticals Inc (CASI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CASI Pharmaceuticals Inc (CASI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
CASI Pharmaceuticals Inc (CASI)'s detailed insider trading history can be found in Insider Trading Tracker table.
CASI Pharmaceuticals Inc Insider Transactions
Peter S Knight Mailing Address
Above is the net worth, insider trading, and ownership report for Peter S Knight. You might contact Peter S Knight via mailing address: 6702 Stein Circle, #642, P.o. Box 4138, Park City Ut 84060.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
